Systems-Integrated Thermostable Vaccine Delivery: Converging Cold-Chain-Free Design, AI-Augmented Formulation, and Climate-Resilient Infrastructure
Molecular Pharmaceutics · 01.12.2025 · 22 (12) · 7285-7312
DOI: 10.1021/acs.molpharmaceut.5c01296 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 30.10.2025. Verfasst von Sonali Das und 5 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Technology Development Centre, Indian Institute of Technology Kharagpur, Kharagpur 721302, India. Hauptthemen laut MEDLINE: Vaccines, Drug Delivery Systems. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 191 Literaturangaben.
Abstract (Originalsprache)
Thermostable vaccine delivery represents a transformative step toward equitable and climate-resilient immunization systems. Unlike conventional vaccines requiring strict cold-chain storage at 2-8 °C, thermostable formulations retain efficacy at elevated ambient temperatures (up to 40-45 °C), enabling deployment in low-resource, remote, and climate-vulnerable regions. Recent advances in excipients, nanoencapsulation, stabilization matrices such as polymers, metal-organic frameworks (MOFs), liposomes, and drying techniques like lyophilization and spray drying have significantly enhanced heat tolerance and shelf life stability. Existing reviews primarily emphasize material innovations and biophysical stabilization strategies, often highlighting case studies and high-throughput screening approaches. However, critical gaps remain regarding systems-level integration of thermostable vaccine platforms. Few studies explore the convergence of digital formulation design, AI-driven development pipelines, geospatial modeling, lifecycle engineering, and carbon-neutral delivery strategies. Similarly, the integration of smart logistics, real-time monitoring, blockchain-based vaccine authentication, and the policy-technology interface required for deployment in conflict zones, postdisaster areas, and regions severely affected by climate change remains underrepresented. Addressing these gaps is essential to move beyond cold-chain elimination toward climate-smart and sustainable vaccine systems capable of meeting the health needs of underserved populations and addressing emerging global immunization challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Advanced Technology Development Centre, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
- Department of Electronics & Electrical Communication Engineering, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
- Department of Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
ORCID-Profile: Ayan Chatterjee, Tarun Kanti Bhattacharyya
Zitieren
APA
Das, S., Chatterjee, A., Manna, J., Das Mandal, S. K., Maiti, T. K., & Bhattacharyya, T. K. (2025). Systems-Integrated Thermostable Vaccine Delivery: Converging Cold-Chain-Free Design, AI-Augmented Formulation, and Climate-Resilient Infrastructure. Molecular Pharmaceutics, 22(12), 7285-7312. https://doi.org/10.1021/acs.molpharmaceut.5c01296
Vancouver
Das S, Chatterjee A, Manna J, Das Mandal SK, Maiti TK, Bhattacharyya TK. Systems-Integrated Thermostable Vaccine Delivery: Converging Cold-Chain-Free Design, AI-Augmented Formulation, and Climate-Resilient Infrastructure. Molecular Pharmaceutics. 2025;22(12):7285-7312. doi:10.1021/acs.molpharmaceut.5c01296
BibTeX
@article{Das2025,
author = {Das, Sonali and Chatterjee, Ayan and Manna, Jhimli and Das Mandal, Shyamal Kumar and Maiti, Tapas Kumar and Bhattacharyya, Tarun Kanti},
title = {Systems-Integrated Thermostable Vaccine Delivery: Converging Cold-Chain-Free Design, AI-Augmented Formulation, and Climate-Resilient Infrastructure},
journal = {Molecular Pharmaceutics},
year = {2025},
volume = {22},
number = {12},
pages = {7285--7312},
doi = {10.1021/acs.molpharmaceut.5c01296}
}
EUVIMED